Details

Last Funding Type

Series C

Last Funding Money Raised

$43M

Industries

Health Care,Medical,Pharmaceutical

Founded date

Jan 1, 2000

Operating Status

Active

Predix is a drug discovery and development company that uses a novel 3D
Discovery and Optimization Engine for GPCR drug candidates and is taking its
novel compounds into the clinic. The discovery engine uses a sophisticated
proprietary algorithm, PREDICT(TM), for computer modeling the 3D structure of
any GPCR target; advanced technologies HYPERION(TM) and RISS(TM) for rapid
high-throughput in silico screening of millions of compounds against the 3D in
silico model of the target; and an integrated medicinal/computational platform
for lead optimization based on the receptor's structure (ICELR-3D(TM)) and
predictive algorithms for important drug properties. In August, Predix and
Physiome Sciences Inc. combined companies and expanded the expertise into ion
channel drug discovery.